GlassScriptPhysician profile
Alexandra A Herzlich
NPI 1932360997
$2,506.70
in general payments reported to CMS, 2019-2025
20 companies · $716 in 2025
The $716 reported for 2025 was more than what a typical Cornea and External Diseases Specialist provider received nationally (typical 2025 total: $477).
See the full distribution for Cornea and External Diseases Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $440 · 2021: $276 · 2022: $188 · 2023: $149 · 2024: $395 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $488.48 | 2019-2022 | |
| Biotissue Holdings INC. | $301.28 | 2022-2025 | |
| Dompe US, INC. | $283.78 | 2019-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $278.21 | 2019-2025 | Cequa, Xelpros |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $220.07 | 2020-2021 | |
| Glaukos Corporation | $167.99 | 2021-2024 | Idose |
| Mallinckrodt Hospital Products INC. | $154.08 | 2021-2024 | Acthar |
| Bausch & Lomb Americas INC. | $101.92 | 2022-2024 | Vyzulta, Xiidra, Prolensa |
| Rxsight INC | $99.60 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Oyster Point Pharma, INC. | $79.03 | 2023-2024 | Tyrvaya, Ryzumvi |
| Alcon Vision LLC | $76.59 | 2022-2025 | Tryptyr, Eysuvis |
| Novartis Pharmaceuticals Corporation | $67.80 | 2020-2021 | |
| Horizon Therapeutics Plc | $46.55 | 2022-2023 | Tepezza |
| Abbvie INC. | $39.06 | 2023-2025 | |
| Astellas Pharma US INC | $21.99 | 2024 | Izervay |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $20.56 | 2024 | |
| Shire North American Group INC | $19.51 | 2019 | |
| Sight Sciences, INC. | $14.52 | 2021 | |
| Eyevance Pharmaceuticals LLC | $12.99 | 2022 | |
| Allergan, INC. | $12.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Herzlich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.